Global radiopharmaceuticals market insightRajesh Sarma
“Global Radiopharmaceuticals Market Insight” Report Highlights
Global Radio Pharmaceuticals Market Overview by Region
Target Patient Base by Region
Radiopharmaceuticals Market Regulation for US, Europe & Canada
Radioisotopes Used in Radiopharmaceuticals
Radiopharmaceutical Clinical Pipeline Insight
Profile of 87 Radiopharmaceuticals Drugs in Clinical Phase
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Global radiopharmaceuticals market insightRajesh Sarma
“Global Radiopharmaceuticals Market Insight” Report Highlights
Global Radio Pharmaceuticals Market Overview by Region
Target Patient Base by Region
Radiopharmaceuticals Market Regulation for US, Europe & Canada
Radioisotopes Used in Radiopharmaceuticals
Radiopharmaceutical Clinical Pipeline Insight
Profile of 87 Radiopharmaceuticals Drugs in Clinical Phase
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) Visit us: http://azothanalytics.com/report/healthcare-pharma/global-nuclear-medicine-market-analysis-by-product-type-diagnostic-therapeutic-by-diagnostic-nuclear-medicine-type-by-therapeutic-nuclear-medicine-type-by-indication-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-r28197
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Refurbished Medical Imaging Equipment Market To Surpass $21.14 Billion By 202...OliviaThomas57
The global refurbished medical imaging equipment market was valued at USD 11.7 billion in 2019 and size is expected to reach USD 21.14 billion by 2027 to grow at a CAGR of 7.7% during the forecast period
NON-ALCOHOLIC STEATOHEPATITIS (NASH): AN ANALYSIS OF DISEASE PREVALENCE, DRUG...MP ADVISORS
This report will provide detailed analysis on NASH disease and Drugs in development in broader pharma market. This report list all the drugs in clinical trial and their design and the population recruited, also tells about the pathways representing possible targets for the treatment of NASH
Booming Refurbished Medical Device MarketVikas Gupta
The growth in the refurbished medical device market has been propelled by various drivers and market-enablers, that are transforming the dynamics globally, throwing up a plethora of opportunities for the investors in this segment
Global radiopharmaceuticals market outlook 2020Rajesh Sarma
“Global Radiopharmaceuticals Market Outlook 2020” Report Highlight:
Global Radiopharmaceutical Market Overview
Global Radiopharmaceuticals Market Dynamics
FDA & EMA Guidelines for Radiopharmaceuticals
Global Radiopharmaceuticals Clinical Pipeline Insight by Company, Indication & Phase
Global Radiopharmaceuticals Clinical Pipeline: 133 Radiopharmaceuticals
Majority Radiopharmaceuticals in Preclinical Phase: 44 Radiopharmaceuticals
Marketed Radiopharmaceuticals: 19 Radiopharmaceuticals
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.
Drug development is challenging at the best of times, and made even harder within the realm of rare diseases. Overall, the largest number of drugs has targeted indications within the therapeutic areas of oncology and infectious disease (ID), with malaria being an area of high interest with both therapeutic and preventive interventions.
View this slideshare to get the most accurate and timely intelligence about rare diseases drug development.
In this detailed 20-page report, containing numerous comparative graphs, you will discover:
- The top 25 Rare Diseases by total drugs in development to date
- Current Rare Disease drug development landscape
- Top 15 originators of drugs in development for Rare Diseases (includes non-rare disease drug counts and % of portfolio dedicated to Rare Diseases)
- Therapeutic area distribution of rare diseases and drugs in development
- The top 5 Rare Diseases by drug count per therapeutic area (TA)
- Rare Infectious Diseases with 10 or more drugs in development
- The top 15 originators developing drugs for Rare Infectious Diseases
- Rare cancers with 10 or more drugs in development
- The top 15 originators developing drugs for rare cancers
- Non-ID, non-cancer Rare Diseases with 20 or more drugs in development
- The top 15 originators developing drugs for non-ID, non-cancer Rare Diseases
China Pharmaceutical Market : SWOT Analysis, Government policies, Business an...Maria Robert
Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=17129.
Pharmaceutical Industry in China – Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges report presented by Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) & by Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)
Experts from Informa’s Medtrack, Trialtrove and Strategic Transactions teams presented a panel discussion at the recent T3 Conference in Orlando, Florida.
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Medical Devices & Diagnostics Asia - Balancing Risk & Reward WhitepaperSimranjit Singh
A whitepaper from Quintiles which looks at the growth potential of Asia pacific for medical devices and the approaches to navigate the complex regulatory pathways.
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an analysis of Porter’s five forces model for the NASH market has also been included.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
The global gene therapy market size was valued at USD 536.43 million in 2018 and is expected to register a CAGR of 33.9% assuming the projected successful commercialization of some of the key therapeutics, that are planned over the forecast period.
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
The global market for biopsy forceps is expected to grow from $ 250.6 million in 2021 to $ 289.1 million in 2026. The market is expected to grow at a CAGR of 2.9% over the forecast period (2021-2026). Some of the market's key participants are Alton, Argon Medical, Boston Scientific, ConMed, Cook Medical, Cordis(J&J), Fujifilm, JingRui, Jiuhong, KARL STORZ, Micro Tech, OLYMPUS, PENTAX (HOYA), Tiansong, Wilson. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for biopsy forceps. The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of biopsy forceps in both established and emerging markets.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
Personalized Medicine Market is Projected to Reach $2,452.5 Billion by 2022Grand View Research
Personalized Medicine (PM) Market Analysis By Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) And Segment Forecasts To 2022
Refurbished Medical Imaging Equipment Market To Surpass $21.14 Billion By 202...OliviaThomas57
The global refurbished medical imaging equipment market was valued at USD 11.7 billion in 2019 and size is expected to reach USD 21.14 billion by 2027 to grow at a CAGR of 7.7% during the forecast period
NON-ALCOHOLIC STEATOHEPATITIS (NASH): AN ANALYSIS OF DISEASE PREVALENCE, DRUG...MP ADVISORS
This report will provide detailed analysis on NASH disease and Drugs in development in broader pharma market. This report list all the drugs in clinical trial and their design and the population recruited, also tells about the pathways representing possible targets for the treatment of NASH
Booming Refurbished Medical Device MarketVikas Gupta
The growth in the refurbished medical device market has been propelled by various drivers and market-enablers, that are transforming the dynamics globally, throwing up a plethora of opportunities for the investors in this segment
Global radiopharmaceuticals market outlook 2020Rajesh Sarma
“Global Radiopharmaceuticals Market Outlook 2020” Report Highlight:
Global Radiopharmaceutical Market Overview
Global Radiopharmaceuticals Market Dynamics
FDA & EMA Guidelines for Radiopharmaceuticals
Global Radiopharmaceuticals Clinical Pipeline Insight by Company, Indication & Phase
Global Radiopharmaceuticals Clinical Pipeline: 133 Radiopharmaceuticals
Majority Radiopharmaceuticals in Preclinical Phase: 44 Radiopharmaceuticals
Marketed Radiopharmaceuticals: 19 Radiopharmaceuticals
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.
Drug development is challenging at the best of times, and made even harder within the realm of rare diseases. Overall, the largest number of drugs has targeted indications within the therapeutic areas of oncology and infectious disease (ID), with malaria being an area of high interest with both therapeutic and preventive interventions.
View this slideshare to get the most accurate and timely intelligence about rare diseases drug development.
In this detailed 20-page report, containing numerous comparative graphs, you will discover:
- The top 25 Rare Diseases by total drugs in development to date
- Current Rare Disease drug development landscape
- Top 15 originators of drugs in development for Rare Diseases (includes non-rare disease drug counts and % of portfolio dedicated to Rare Diseases)
- Therapeutic area distribution of rare diseases and drugs in development
- The top 5 Rare Diseases by drug count per therapeutic area (TA)
- Rare Infectious Diseases with 10 or more drugs in development
- The top 15 originators developing drugs for Rare Infectious Diseases
- Rare cancers with 10 or more drugs in development
- The top 15 originators developing drugs for rare cancers
- Non-ID, non-cancer Rare Diseases with 20 or more drugs in development
- The top 15 originators developing drugs for non-ID, non-cancer Rare Diseases
China Pharmaceutical Market : SWOT Analysis, Government policies, Business an...Maria Robert
Purchase a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=17129.
Pharmaceutical Industry in China – Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges report presented by Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) & by Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)
Experts from Informa’s Medtrack, Trialtrove and Strategic Transactions teams presented a panel discussion at the recent T3 Conference in Orlando, Florida.
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Medical Devices & Diagnostics Asia - Balancing Risk & Reward WhitepaperSimranjit Singh
A whitepaper from Quintiles which looks at the growth potential of Asia pacific for medical devices and the approaches to navigate the complex regulatory pathways.
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an analysis of Porter’s five forces model for the NASH market has also been included.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
The global gene therapy market size was valued at USD 536.43 million in 2018 and is expected to register a CAGR of 33.9% assuming the projected successful commercialization of some of the key therapeutics, that are planned over the forecast period.
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
The global market for biopsy forceps is expected to grow from $ 250.6 million in 2021 to $ 289.1 million in 2026. The market is expected to grow at a CAGR of 2.9% over the forecast period (2021-2026). Some of the market's key participants are Alton, Argon Medical, Boston Scientific, ConMed, Cook Medical, Cordis(J&J), Fujifilm, JingRui, Jiuhong, KARL STORZ, Micro Tech, OLYMPUS, PENTAX (HOYA), Tiansong, Wilson. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for biopsy forceps. The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of biopsy forceps in both established and emerging markets.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
Personalized Medicine Market is Projected to Reach $2,452.5 Billion by 2022Grand View Research
Personalized Medicine (PM) Market Analysis By Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) And Segment Forecasts To 2022
The global organ-on-a-chip market generated revenue of US$ 23.3 million in 2020 and is expected to reach US$ 116.7 million by 2025 with a CAGR of 38.0% in the forecast period. The organ-on-a-chip market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global organ-on-a-chip market. In qualitative terms, the organ-on-a-chip market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of organ-on-a-chip in various segments such as by Offerings, type, application & end-user at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.
Global Veterinary Reference Laboratory (VRL) Market Research, 2018 to 2025Signitech
The global veterinary reference laboratory (VRL) market size was valued at USD 2.350 billion in 2016 and is expected to grow with CAGR of 9.1% during the forecast period.
Radiopharmaceuticals - A Market Overview.pdfsasharkl87
These slides briefly cover the history of radiopharmaceuticals and how they have contributed towards detailed diagnostics and precision therapy over the decades. These slides also discuss the overall market value by region and how it will continue to grow for years to come.
Dialysis Market by Product Type, Distribution Channel, End User 2023-2028IMARC Group
The global dialysis market size reached US$ 110.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 148.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.
More Info:- https://www.imarcgroup.com/dialysis-market
Global antibody drug conjugate market & pipeline insight2020KuicK Research
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Download Global antibody drug conjugate market & pipeline insight2020KuicK Research
\" Global Antibody Drug Conjugate Market & Pipeline Insight 2020\" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...Grand View Research
Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022
Australia Lung Cancer Drugs Market Analysis Sample ReportInsights10
Lung cancer is the fifth most common type of cancer affecting the Australian population, therefore the Australian lung cancer drugs market is projected to grow during the forecast period. The market is segmented by type, treatment, end user, route of administration, and distribution channel. To get a detailed report, contact us at - info@insights10.com
Medical Marijuana Market Size, Share, Trends and Growth Analysis Research, 20...Signitech
The global medical marijuana market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period.
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
PPT: Medical Cyclotron Market to Witness Huge Growth during 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical cyclotron market reached a value of US$ 192.6 Million in 2021. Medical cyclotron represents a type of particle accelerator, wherein an alternating electric field propels a beam of charged units in a spiral pattern. This assists in producing protons and radioactive isotopes for medical imaging, diagnosis, and treatment of various cardiovascular disorders.
Similar to Asia Pacific Radiopharmaceuticals Market Size, Growth | Industry Report, 2024 (20)
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Asia Pacific Radiopharmaceuticals Market Size, Growth | Industry Report, 2024
1. Follow Us:
Asia Pacific Radiopharmaceuticals Market Analysis, Size,
Growth, Share & Forecast to 2024 | Grand View Research Inc.
The APAC Radiopharmaceuticals/Nuclear Medicine Market is expected to reach USD 2.9 billion by 2024,
according to the new report by Grand View Research, Inc. Radiopharmaceuticals are widely used in the field of
oncology, and cardiovascular diseases. Ongoing research and studies demonstrating positive results is
widening the scope of radioisotope applications for the diagnosis and treatment of bone diseases, respiratory
diseases, thyroid-related diseases, and conditions of the digestive tract. Along with these applications, the
radioisotopes are largely used in radiopharmacology to study drug movement in lab subjects.
Gamma emitter Technetium-99m is the most commonly used radioisotope in radiopharmaceuticals. Other
widely used radioisotopes include Fluorine-18, Indium-111, and Iodine-131. Numerous research studies are
further expanding the application areas of radiopharmaceuticals in diagnostics as well as in therapeutics.
Adoption of PET as a diagnostic tool is rapidly increasing since it offers high accuracy over other diagnostic
techniques. The accuracy in the diagnosis has a direct impact on decision-making and treatment monitoring
process. PET is commonly integrated with X-ray and computed tomography to increase the accuracy. The
growing demand for these diagnostic procedures is expected to fuel the market growth during the forecast
period.
Currently available cancer treatment options, such as chemotherapy and radiation therapy, include drugs and
radiations, which are non-target specific. Thus, these therapies have a major disadvantage of affecting the
whole body or the organs surrounding the target site. Radioisotopes have an advantage over these techniques
since they aid in targeting specifically the tumor without affecting the surrounding body parts. Thus, benefits
associated with these diagnostic and treatment procedures is augmenting the demand for
radiopharmaceuticals in disease treatment and diagnosis.
“Asia Pacific Radiopharmaceuticals Market to Reach $2.9 Billion By 2024”
2. Follow Us:
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/asia-pacific-
radiopharmaceuticals-market
Further key findings from the study suggest:
• The buyers of radiopharmaceutical include hospitals, physicians, diagnostic laboratories, research
institutes and others. Hospitals form the biggest buyer groups owing to their high patient turnover and
greater financing capabilities.
• Therapeutic products such as Alpha Emitters, Beta Emitters and Brachytherapy are anticipated to
exhibit lucrative growth. Emergence of new treatment options for thyroid and other diseases is
expected to support the growth over the forecast period.
• The key diagnostic application areas of radiopharmaceuticals formed the largest market in 2015. These
applications are in cardiology, neurology, oncology, and thyroid. Advent of accurate diagnostic methods
and high burden of disorders supported the growth of this segment.
• Thailand in South East Asia and China are expected to dominate the APAC radiopharmaceutical
market. Efforts undertaken by the UN and other local healthcare authorities in this region are expected
to result in installation of more PET and SPECT systems, thereby driving the demand.
• Key players of the industry include Nordion, Inc., Bayer AG, Mallinckrodt Public Limited company, GE
Healthcare, Bracco Imaging S.P.A and government initiatives such as Institute of Radioisotopes and
The Australian Nuclear Science and Technology Organization (ANSTO)
Grand View Research has segmented the APAC radiopharmaceuticals market on the basis of product:
APAC Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2013 - 2024)
• Diagnostics
o SPECT
o TC-99m
o TL-201
o GA-67
o I-123
o Others
o PET
o F-18
o RB-82
o Others
3. Follow Us:
• Therapeutics
o Alpha Emitters
o RA-223
o Beta Emitters
o I-131
o Y-90
o SM-153
o Re-186
o Lu-117
o Others
o Brachytherapy
o Cesium-131
o Iodine-125
o Palladium-103
o Iridium-192
o Others
Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2013 - 2024)
• South East Asia
o Indonesia
o Thailand
o Laos
o Myanmar
o Philippines
o Malaysia
o Vietnam
o Cambodia
4. Follow Us:
• Rest of Asia Pacific
o Japan
o China
o India
Table of Content
Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Rising incidence of cancer and cardiovascular disease
4.1.1.2 Widening applications of radiopharmaceuticals
4.1.1.3 Growing demand for the accurate diagnostic methods
4.1.2 Market Restraint Analysis
4.1.2.1 Stringent regulation for production, storage, and usage
4.1.2.2 High costs involved in the procedure
4.2 Radiopharmecuticals - PESTLE Analysis
4.3 Industry Analysis - Porter’s
4.4 Penetration Index
4.5 Radiopharmaceuticals: Buyer profile
4.6 List of suppliers
4.7 Average Selling Price
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
5.1 Radiopharmaceuticals market: Product movement analysis
5.2 Diagnostic products
5.2.1 Diagnostic products market, 2013 - 2024 (USD Million)
5.2.2 SPECT
5.2.2.1 SPECT products market, 2013 - 2024 (USD Million)
8. Follow Us:
7.3.2 Japan
7.3.2.1 Japan radiopharmaceuticals market, 2013 - 2024 (USD Million)
7.3.3 China
7.3.3.1 China radiopharmaceuticals market, 2013 - 2024 (USD Million)
7.3.4 India
7.3.4.1 India radiopharmaceuticals market, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Mallinckrodt public limited company
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 GE Healthcare
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Jubilant Life Sciences
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Bracco Imaging S.p.A
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Nordion, Inc.
8.6.1 Company Overview
9. Follow Us:
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 The Institute for Radioelements (The IRE)
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Australian Nuclear Science & Technology Organization (ANSTO)
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.9 NTP Radioisotopes SOC Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Eczacibasi-Monrol
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
10. Follow Us:
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based research across a range of
industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com